Director/PDMR Shareholding

RNS Number : 8156A
Kromek Group PLC
29 March 2017
 

29 March 2017

 

Kromek Group plc

("Kromek" or the "Company")

 

Director/PDMR Shareholding

 

 

Kromek (AIM: KMK), a radiation detection technology company focusing on the medical, security and nuclear markets, announces that it has received notification that, on 24 March 2017,  Berry Beumer, Chief Operating Officer of Kromek, purchased 80,000 Ordinary Shares of 1 pence each ("Ordinary Shares") in the Company at a price of 29.35 pence per share.

 

Following the purchase, Mr. Beumer has an interest in 80,000 Ordinary Shares representing 0.03% of the entire current issued share capital of the Company.

 

Enquiries

Kromek Group plc

01740 626 060

Arnab Basu, CEO

Derek Bulmer, CFO

 

 

 

Cenkos Securities plc

0207 397 8900

Bobbie Hilliam (NOMAD)

Harry Pardoe

 

 

 

Luther Pendragon

0207 618 9100

Harry Chathli, Claire Norbury, Alexis Gore

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Berry Beumer

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Operating Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Kromek Group plc

b)

 

LEI

 

 

N/a

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of 1p each

 

 

 

 

b)

 

Nature of the transaction

 

 

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

29.35p  

 

80,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

80,000 Ordinary Shares

 

 

29.35p per Ordinary Share

 

e)

 

Date of the transaction

 

 

24 March 2017

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

About Kromek Group plc

 

Kromek Group plc is a UK technology company (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT").  Using its core CZT technology, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

 

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

                                                                                  

The Group's business model provides a vertically integrated technology offering to customers, from the growth of CZT crystals to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

 

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

 

Currently, the Group has over a hundred full time employees across its global operations. Further information on Kromek Group is available at www.kromek.com.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKFDDCBKDFNB

Companies

Kromek Group (KMK)
UK 100

Latest directors dealings